Gina Mazzariello - Feb 22, 2022 Form 3 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Stock symbol
AMLX
Transactions as of
Feb 22, 2022
Transactions value $
$0
Form type
3
Date filed
2/28/2022, 04:02 PM
Next filing
Feb 28, 2023

No securities are beneficially owned.